AV
AV8 Ventures
Activity from announced rounds
Activity in this selectionOct 18, 2026 · Sep 19, 2026
AV8 Ventures is an investment firm with recorded relationships to Think Bioscience and Shennon Biotechnologies.
Recorded funding activity
Think Bioscience develops small-molecule medicines for historically difficult drug targets. Shennon develops precision T-cell engager immunotherapies for solid tumors. The two financing histories connect the firm to different drug-development approaches without establishing a complete sector or portfolio allocation.
Sources
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.